ARCHIVES

Phase III Trial Fails to Extend OS After Meeting Primary Endpoint Of Durable Response Rate

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Increases R01 Grant Payline From 12th to 15th Percentile.

June 29, 2007

NTP Board Approves Concept Of Human Cell Assay For Genetic Toxicity

March 25, 1983

Simmonds Succeeds Young As ACS President; Lame-Duck Session Unlikely To Approve Funding Bills

November 8, 2002

NIH Signs Agreement For Use Of Five Stem Cell Lines.

September 7, 2001

NCI’s Justification For 1981 Budget

June 8, 1979

NIH establishes new clinical science awards to eventually replace General Clinical Research Centers.

October 21, 2005